ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Optimi Health Corp (OP:OPTHF)

0.2480 +0.0100 (+4.20%)

Streaming Delayed Price Updated: 1:21 PM EDT, May 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	24,524
Open	0.1719
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.2380
Today's Range	0.1719 - 0.2480
52wk Range	0.1000 - 0.2946
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

PsychedelicNewsBreaks – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) Launches Ibogaine Initiative Amid U.S. Policy Shift

April 21, 2026

Via Investor Brand Network

Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products

April 20, 2026

(April 20, 2026) - Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer of regulated psychedelic

Via PressReach

Performance

YTD	+7.8%	+7.8%
1 Month	+9.3%	+9.3%
3 Month	-2.7%	-2.7%
6 Month	+3.1%	+3.1%
1 Year	+40.9%	+40.9%

More News

Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering

March 16, 2026

Via PressReach

Optimi Health Completes MD-MA Export for PTSD Treatment Under Australia’s Authorised Prescriber Scheme

February 09, 2026

Via PressReach

Optimi Health Completes First 2026 Production of MD-MA and Psilo Capsules

January 26, 2026

Via PressReach

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition ↗

September 16, 2024

Via Benzinga

New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia ↗

June 05, 2024

Via Benzinga

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More ↗

April 17, 2024

Via Benzinga

Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More ↗

April 17, 2024

Via Benzinga

Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute ↗

April 09, 2024

Via Benzinga

Two Top Biotechs Forge MDMA Supply Deals For Clinical Research ↗

March 26, 2024

Via Benzinga

Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review ↗

March 16, 2024

Via Benzinga

Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More ↗

March 01, 2024

Via Benzinga

Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More ↗

January 26, 2024

Via Benzinga

Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More ↗

January 08, 2024

Via Benzinga

Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More ↗

September 11, 2023

Via Benzinga

Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing ↗

September 08, 2023

Via Benzinga

Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More ↗

August 14, 2023

Via Benzinga

Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player ↗

August 01, 2023

Via Benzinga

MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University ↗

June 20, 2023

Via Benzinga

Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More ↗

May 23, 2023

Via Benzinga

The Psychedelic Mushrooms Market; Between Legitimate Harvesting And Illegal Retail Sales ↗

May 17, 2023

Via Benzinga

Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More ↗

May 15, 2023

Via Benzinga

Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal ↗

May 11, 2023

Via Benzinga

What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry ↗

April 03, 2023

Via Benzinga

Frequently Asked Questions

Is Optimi Health Corp publicly traded?

Yes, Optimi Health Corp is publicly traded.

What exchange does Optimi Health Corp trade on?

Optimi Health Corp trades on the OTC Traded

What is the ticker symbol for Optimi Health Corp?

The ticker symbol for Optimi Health Corp is OPTHF on the OTC Traded

What is the current price of Optimi Health Corp?

The current price of Optimi Health Corp is 0.2480

When was Optimi Health Corp last traded?

The last trade of Optimi Health Corp was at 05/08/26 01:21 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.